Valneva SE VALN
NASDAQ VALN
$6.95 -0.11 (-1.63%)
As of: Sep 4, 2026 · 12:37 PM EDT

Valneva SE (VALN) Other Non Operating Income (2021 - 2026)

Valneva SE (VALN) posted Other Non Operating Income of -$3.5 million for Q1 2026, down 233.91% sequentially from -$1.0 million in Q4 2025, and down 190.62% YoY from $3.9 million in Q1 2025.

Analysis

Valneva SE (VALN) Other Non Operating Income (2021 - 2026) Analysis & Trends

Valneva SE has reported Other Non Operating Income for 6 years, with the latest figure at -$3.5 million in Q1 2026.

  • Quarterly Other Non Operating Income fell 190.62% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$16.4 million (down 264.67% YoY) and the FY2025 annual result came in at -$8.4 million, down 341.99% from the prior year.
  • Other Non Operating Income eased to -$3.5 million in Q1 2026 per VALN's latest filing, from -$1.0 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $14.2 million in Q4 2022 and troughed at -$16.5 million in Q3 2025.
  • A 5-year average of -$970862.6 and a median of -$1.0 million in 2025 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 402.71% in 2025, down 1012.12% in 2025.
  • Over 5 years, Other Non Operating Income stood at $14.2 million in 2022, then tumbled by 46.8% to $7.5 million in 2023, then fell by 12.22% to $6.6 million in 2024, then plunged by 115.81% to -$1.0 million in 2025, then sank by 233.91% to -$3.5 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$3.5 million, -$1.0 million, and -$16.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Valneva SE 584.00 Mn 442.75 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.07 Mn
Mar 31, 2026 -3.50 Mn
Dec 31, 2025 -1.05 Mn
Sep 30, 2025 -16.46 Mn
Jun 30, 2025 4.66 Mn
Mar 31, 2025 3.86 Mn
Dec 31, 2024 6.63 Mn
Sep 30, 2024 -1.48 Mn
Jun 30, 2024 926,123.32
Mar 31, 2024 -2.73 Mn
Dec 31, 2023 7.55 Mn
Sep 30, 2023 -6.49 Mn
Jun 30, 2023 1.47 Mn
Mar 31, 2023 3.40 Mn
Dec 31, 2022 14.19 Mn
Sep 30, 2022 -15.97 Mn
Jun 30, 2022 -8.80 Mn
Mar 31, 2022 -2.71 Mn
Dec 31, 2021 3.20 Mn
Sep 30, 2021 -4.01 Mn